Total Payments
$696.53
2024 Payments
$432.96
Companies
8
Transactions
26
Medicare Patients
1,256
Medicare Billing
$295,233
Payment Breakdown by Category
Food & Beverage$696.53 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $696.53 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $196.35 | 7 | $0 (2024) |
| Bioventus LLC | $155.06 | 1 | $0 (2021) |
| Averitas Pharma Inc. | $95.95 | 5 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $74.11 | 4 | $0 (2024) |
| ABBVIE INC. | $74.02 | 3 | $0 (2024) |
| Abbott Laboratories | $67.71 | 4 | $0 (2023) |
| Curonix LLC | $22.05 | 1 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $11.28 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $432.96 | 18 | Boston Scientific Corporation ($182.88) |
| 2023 | $97.23 | 6 | Abbott Laboratories ($67.71) |
| 2021 | $166.34 | 2 | Bioventus LLC ($155.06) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/08/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $133.93 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/03/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/17/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: Opioid Analgesic | ||||||
| 04/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Opioid Analgesic | ||||||
| 03/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/28/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 01/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Opioid Analgesic | ||||||
| 01/05/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/08/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Neuromodulation | ||||||
| 10/24/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: Opioid Analgesic | ||||||
| 07/17/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Neuromodulation | ||||||
| 05/02/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Neuromodulation | ||||||
| 02/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Neuromodulation | ||||||
| 01/19/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/09/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Chronic Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 192 | 694 | $211,386 | $49,319 |
| 2022 | 4 | 237 | 1,025 | $330,221 | $75,155 |
| 2021 | 5 | 346 | 1,162 | $371,672 | $84,306 |
| 2020 | 7 | 481 | 1,269 | $412,268 | $86,453 |
Total Patients
1,256
Total Services
4,150
Medicare Billing
$295,233
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 515 | $159,274 | $35,175 | 22.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 72 | 148 | $27,226 | $8,725 | 32.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 14 | 16 | $14,309 | $3,116 | 21.8% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 14 | 15 | $10,577 | $2,302 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 771 | $235,911 | $53,666 | 22.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 84 | 197 | $47,686 | $11,591 | 24.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 24 | 34 | $30,407 | $6,487 | 21.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 22 | 23 | $16,218 | $3,412 | 21.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 173 | 860 | $261,199 | $61,342 | 23.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 107 | 214 | $62,259 | $12,544 | 20.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 40 | 41 | $28,910 | $6,420 | 22.2% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 14 | 14 | $12,521 | $2,420 | 19.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 33 | $6,783 | $1,579 | 23.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 219 | 803 | $243,887 | $50,907 | 20.9% |
| 80307 | Testing for presence of drug | Office | 2020 | 134 | 243 | $70,696 | $14,573 | 20.6% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 33 | 45 | $40,245 | $8,733 | 21.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 48 | 55 | $38,781 | $8,415 | 21.7% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 19 | 21 | $10,814 | $2,378 | 22.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 38 | $7,811 | $1,442 | 18.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 13 | 64 | $33.92 | $5.67 | 16.7% |
About Adeline Rouser, NP
Adeline Rouser, NP is a Nurse Practitioner healthcare provider based in Brentwood, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1184021438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Adeline Rouser, NP has received a total of $696.53 in payments from pharmaceutical and medical device companies, with $432.96 received in 2024. These payments were reported across 26 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($696.53).
As a Medicare-enrolled provider, Rouser has provided services to 1,256 Medicare beneficiaries, totaling 4,150 services with total Medicare billing of $295,233. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Brentwood, TN
- Active Since 12/02/2014
- Last Updated 02/22/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1184021438
Products in Payments
- WaveWriter Alpha Prime 16 (Device) $196.35
- Durolane (Device) $155.06
- QUTENZA (Drug) $95.95
- UBRELVY (Drug) $74.02
- PROCLAIM (Device) $67.71
- Belbuca (Drug) $55.04
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $22.05
- XTAMPZA (Drug) $19.07
- BELBUCA (Drug) $11.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Brentwood
Angela Morehead, Fnp, FNP
Nurse Practitioner — Payments: $58,947
Nurse Practitioner $58,947
Ms. Abigail James, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $47,988
Nurse Practitioner $47,988
Amy Hendon, Np, NP
Nurse Practitioner — Payments: $2,092
Nurse Practitioner $2,092
Abigail Davis, Aprn, APRN
Nurse Practitioner — Payments: $1,932
Nurse Practitioner $1,932
Stefanie Morris, Fnp, FNP
Nurse Practitioner — Payments: $799.37
Nurse Practitioner $799.37
Amanda Kralick, Np, NP
Nurse Practitioner — Payments: $371.70
Nurse Practitioner $371.70